E Fund Management (Hong Kong) Co., Ltd. Legend Biotech Corp Transaction History

E Fund Management (Hong Kong) Co., Ltd.

$167 Million
Q3 2024

A detailed history of E Fund Management (Hong Kong) Co., Ltd. transactions in Legend Biotech Corp stock. As of the latest transaction made, E Fund Management (Hong Kong) Co., Ltd. holds 53,710 shares of LEGN stock, worth $2.2 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares

53,710

Previous 58,426 8.07%

Holding current value

$2.2 Million

Previous $2.59 Million 1.16%

% of portfolio

1.57%

Previous 1.59%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$43.55 - $59.88 $205,381 - $282,394	-4,716 Reduced 8.07%	53,710 $2.62 Million
Q2 2024 Jul 12, 2024	BUY	$39.5 - $57.22 $54,273 - $78,620	1,374 Added 2.41%	58,426 $2.59 Million
Q1 2024 Apr 24, 2024	SELL	$55.06 - $69.99 $376,885 - $479,081	-6,845 Reduced 10.71%	57,052 $3.2 Million
Q4 2023 Jan 05, 2024	BUY	$57.25 - $69.74 $637,650 - $776,764	11,138 Added 21.11%	63,897 $3.85 Million
Q3 2023 Oct 12, 2023	BUY	$63.16 - $76.5 $68,212 - $82,620	1,080 Added 2.09%	52,759 $3.54 Million
Q2 2023 Jul 18, 2023	SELL	$46.28 - $75.01 $149,669 - $242,582	-3,234 Reduced 5.89%	51,679 $3.57 Million
Q1 2023 Apr 21, 2023	BUY	$43.42 - $57.37 $950,029 - $1.26 Million	21,880 Added 66.24%	54,913 $2.65 Million
Q4 2022 Feb 01, 2023	BUY	$38.8 - $55.46 $931 - $1,331	24 Added 0.07%	33,033 $1.65 Million
Q3 2022 Oct 24, 2022	BUY	$38.15 - $57.1 $59,704 - $89,361	1,565 Added 4.98%	33,009 $1.35 Million
Q2 2022 Jul 13, 2022	BUY	$33.54 - $55.0 $165,050 - $270,655	4,921 Added 18.55%	31,444 $1.73 Million
Q1 2022 Apr 12, 2022	BUY	$31.02 - $48.18 $545,827 - $847,775	17,596 Added 197.11%	26,523 $1.08 Million
Q4 2021 Feb 07, 2022	BUY	$41.14 - $56.98 $367,256 - $508,660	8,927 New	8,927 $416,000

Others Institutions Holding LEGN

# of Institutions

225

Shares Held

74.3M

Call Options Held

279K

Put Options Held

350K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.85B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management (Hong Kong) Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management (Hong Kong) Co., Ltd. with notifications on news.

Account

E Fund Management (Hong Kong) Co., Ltd. Legend Biotech Corp Transaction History